title: RGD peptide-modified adenovirus expressing hepatocyte growth factor and X-linked inhibitor of apoptosis improves islet transplantation.
abstract: BACKGROUND
  Islet transplantation has the potential for treating type I diabetes; however, its widespread clinical application is limited by the massive apoptotic cell death and poor revascularization of transplanted islet grafts.
  
  
  METHODS
  We constructed a surface-modified adenoviral vector with RGD (Arg-Gly-Asp) sequences encoding human X-linked inhibitor of apoptosis and hepatocyte growth factor (RGD-Adv-hHGF-hXIAP). In vitro transgene expression in human islets was determined by enzyme-liniked immunosorbent assay. RGD-Adv-hHGF-hXIAP-transduced human islets were transplanted under the kidney capsule of streptozotocin-induced diabetic NOD/SCID mice. The blood glucose levels of mice were measured weekly. The kidneys bearing islets were isolated at the end of the experiment and subjected to immunofluorescence staining.
  
  
  RESULTS
  The transduction efficiency on human islets was significantly improved using RGD-modified adenovirus. HGF and XIAP gene expressions were dose-dependent after viral transduction. When exposed to a cocktail of inflammatory cytokines, RGD-Adv-hHGF-hXIAP-transduced human islets showed decreased caspase 3 activity and reduced apoptotic cell death. Prolonged normoglycemic control could be achieved by transplanting RGD-Adv-hHGF-hXIAP-transduced human islets. Immunofluorescence staining of kidney sections bearing RGD-Adv-hHGF-hXIAP-transduced islets was positive for insulin and von Willebrand factor (vWF) at 200 days after transplantation.
  
  
  CONCLUSIONS
  These results indicated that ex vivo transduction of islets with RGD-Adv-hHGF-hXIAP decreased apoptotic islet cell death and improved islet revascularization, and eventually might improve the outcome of human islet transplantation.
authors.affiliation: Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, USA.
authors.forename: Hao
authors.initials: H
authors.lastname: Wu
authors.forename: A-Rum
authors.initials: AR
authors.lastname: Yoon
authors.forename: Feng
authors.initials: F
authors.lastname: Li
authors.forename: Chae-Ok
authors.initials: CO
authors.lastname: Yun
authors.forename: Ram I
authors.initials: RI
authors.lastname: Mahato
mesh_terms: D000256:Adenoviridae; D000818:Animals; D017209:Apoptosis / Q000235:genetics; D001786:Blood Glucose / Q000235:genetics; D003921:Diabetes Mellitus, Experimental / Q000235:genetics / Q000628:therapy*; D015967:Gene Expression Regulation, Viral; D005822:Genetic Vectors; D017228:Hepatocyte Growth Factor / Q000235:genetics / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000235:genetics / Q000378:metabolism; D016381:Islets of Langerhans Transplantation; D007668:Kidney / Q000473:pathology; D008297:Male; D051379:Mice; D016513:Mice, SCID; D009842:Oligopeptides / Q000235:genetics / Q000378:metabolism; D051636:X-Linked Inhibitor of Apoptosis Protein / Q000235:genetics / Q000378:metabolism; D014841:von Willebrand Factor / Q000235:genetics / Q000378:metabolism
chemical_list: D001786:Blood Glucose; D007328:Insulin; D009842:Oligopeptides; D051636:X-Linked Inhibitor of Apoptosis Protein; D014841:von Willebrand Factor; D017228:Hepatocyte Growth Factor; C047981:arginyl-glycyl-aspartic acid
references.citation: Nat Med. 2001 Jan;7(1):33-40
references.pmid: 11135613
references.citation: Pharm Res. 2009 Mar;26(3):587-96
references.pmid: 19002565
references.citation: Diabetes. 2004 Mar;53(3):624-32
references.pmid: 14988246
references.citation: Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):247-52
references.pmid: 11134526
references.citation: Cell. 2001 Mar 9;104(5):781-90
references.pmid: 11257231
references.citation: Mol Ther. 2004 Feb;9(2):189-97
references.pmid: 14759803
references.citation: J Leukoc Biol. 1996 Dec;60(6):729-36
references.pmid: 8975875
references.citation: JAMA. 2005 Feb 16;293(7):830-5
references.pmid: 15713772
references.citation: Cell Death Differ. 2002 Sep;9(9):881-92
references.pmid: 12181739
references.citation: J Vis Exp. 2007;(9):404
references.pmid: 18989445
references.citation: J Control Release. 2009 Dec 16;140(3):262-7
references.pmid: 19376168
references.citation: Pharmacol Rev. 2006 Jun;58(2):194-243
references.pmid: 16714486
references.citation: J Clin Invest. 1999 Feb;103(4):579-87
references.pmid: 10021467
references.citation: Mol Cancer Ther. 2005 Dec;4(12):1821-9
references.pmid: 16373697
references.citation: Acta Diabetol. 1992;28(3-4):233-8
references.pmid: 1576361
references.citation: Transplant Proc. 1994 Apr;26(2):688
references.pmid: 7513464
references.citation: Mol Pharm. 2008 Nov-Dec;5(6):1093-102
references.pmid: 18828606
references.citation: Cell. 1993 Apr 23;73(2):309-19
references.pmid: 8477447
references.citation: Cancer Gene Ther. 2005 Jan;12(1):61-71
references.pmid: 15375379
references.citation: Transplantation. 1991 Jan;51(1):76-85
references.pmid: 1987709
references.citation: Pharm Res. 2006 Sep;23(9):1970-82
references.pmid: 16906455
references.citation: J Clin Invest. 2004 Feb;113(4):516-27
references.pmid: 14966561
references.citation: J Immunol. 1995 Sep 1;155(5):2564-70
references.pmid: 7650386
references.citation: Pharm Res. 1997 Jul;14(7):853-9
references.pmid: 9244140
references.citation: Diabetes. 2001 Dec;50(12):2752-62
references.pmid: 11723058
references.citation: Gene Ther. 2004 Jul;11(14):1105-16
references.pmid: 15238996
references.citation: EMBO J. 1999 Oct 1;18(19):5242-51
references.pmid: 10508158
references.citation: Transplantation. 2003 Jul 15;76(1):252-61
references.pmid: 12865820
references.citation: Curr Opin Immunol. 1991 Dec;3(6):941-8
references.pmid: 1665333
references.citation: Nat Genet. 1995 Oct;11(2):191-7
references.pmid: 7550348
references.citation: Diabetes. 2005 Jul;54(7):2060-9
references.pmid: 15983207
references.citation: J Virol. 1997 Nov;71(11):8221-9
references.pmid: 9343173
references.citation: Mol Pharm. 2010 Oct 4;7(5):1655-66
references.pmid: 20677802
references.citation: J Mol Med (Berl). 2003 Aug;81(8):455-70
references.pmid: 12879149
references.citation: Acta Diabetol Lat. 1990 Jul-Sep;27(3):185-95
references.pmid: 2075782
references.citation: Diabetes. 2004 Dec;53(12):3107-14
references.pmid: 15561940
references.citation: Cell Death Differ. 2003 May;10(5):508-15
references.pmid: 12728249
references.citation: Diabetes. 1984 Apr;33(4):376-82
references.pmid: 6423431
references.citation: Ann N Y Acad Sci. 2008 Dec;1150:230-3
references.pmid: 19120301
references.citation: J Virol. 1998 Dec;72(12):9706-13
references.pmid: 9811704
references.citation: Acta Diabetol. 2002 Dec;39(4):229-33
references.pmid: 12486498
references.citation: Nature. 1990 Aug 30;346(6287):844-7
references.pmid: 2118234
references.citation: Endocrinology. 2003 Aug;144(8):3683-91
references.pmid: 12865351
references.citation: Mol Pharm. 2009 Jan-Feb;6(1):274-84
references.pmid: 19067524
references.citation: J Biol Chem. 2003 Jan 3;278(1):343-51
references.pmid: 12403787
references.citation: J Virol. 1999 Jun;73(6):5156-61
references.pmid: 10233980
references.citation: J Virol. 1996 Jul;70(7):4805-10
references.pmid: 8676512